Registry for young patients with atrial fibrillation
Atrial Fibrillation in Young Patients: a Prospective Multicentre Registry
This study is collecting information from young people under 35 with atrial fibrillation to see how their condition affects them and how it’s treated.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | N/A to 35 Years |
| Sex | All |
| Sponsor | University Hospital, Caen Academic / other |
| Locations | 1 site (Caen, Normandy) |
| Trial ID | NCT04776759 on ClinicalTrials.gov |
What this trial studies
This registry focuses on young patients aged 35 and under who have been diagnosed with atrial fibrillation. It aims to collect data on various factors such as demographics, physical activity, toxicology, and genetics, as well as current management practices including anticoagulation and anti-arrhythmic treatments. By observing these patients, the registry seeks to understand the etiology and long-term outcomes of atrial fibrillation in this age group. The study will follow standard care guidelines for patient management.
Who should consider this trial
Good fit: Ideal candidates for this registry are individuals aged 35 or younger who have experienced their first episode of atrial fibrillation.
Not a fit: Patients over the age of 35 or those with prior episodes of atrial fibrillation will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could provide valuable insights into the management and outcomes of atrial fibrillation in young patients, potentially leading to improved treatment strategies.
How similar studies have performed: While there may be studies on atrial fibrillation in older populations, this specific focus on young patients is relatively novel and has not been extensively explored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * First episode of atrial fibrillation * Less than 35-year-old * Diagnostic by 12-lead ECG or continuous monitoring (minimal duration 30 seconds) * French Social Security number Exclusion Criteria: * Transvenous cardiac implantable electronic device (insertable cardiac monitors are not an exclusion criteria)
Where this trial is running
Caen, Normandy
- Caen University Hospital — Caen, Normandy, France (Recruiting)
Study contacts
- Study coordinator: Pierre Ollitrault, MD, MSc
- Email: ollitrault-p@chu-caen.fr
- Phone: 0231063106
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.